• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Down 1.78% Nasdaq Down 1.35%

    Vanda Pharmaceuticals, Inc. (VNDA)

    -NasdaqGM
    11.98 Up 0.19(1.61%) 11:20AM EDT - Nasdaq Real Time Price
    Add to Portfolio
    Prev Close:11.79
    Open:11.52
    Bid:11.97 x 600
    Ask:11.98 x 200
    1y Target Est:21.00
    Beta:2.36199
    Earnings Date:Oct 26 - Oct 30 (Est.)
    Day's Range:11.50 - 12.05
    52wk Range:8.34 - 15.51
    Volume:268,665
    Avg Vol (3m):857,583
    Market Cap:506.58M
    P/E (ttm):9.27
    EPS (ttm):1.29
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Comparison

    Symbol% ChgMkt Cap
    VNDAUp 1.61%506.58M
    LLYDown 2.03%85.44B
    AZNDown 0.77%78.47B
    JNJDown 1.55%256.20B

    Key Statistics

    Forward P/E (1 yr):N/A
    P/S (ttm):6.24
    Ex-Dividend Date:N/A

    Analysts

    Annual EPS Est (Dec-15) :-0.70
    Quarterly EPS Est (Sep-15) :-0.21
    Mean Recommendation*:1.5
    PEG Ratio (5 yr expected):-1.09

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    Vanda Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of products for the treatment of central nervous system disorders. View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback